What is more impressive and far less likely to be an outlier is the response seen in the higher dose levels after one dose.
“In cohorts 2 and 3 (8 and 12GBq, respectively), PSA reductions of greater than 35% were observed in almost 80% (78%, 7/9) of participants and PSA was reduced by over 80% in 44% (4/9) of participants so far.”
What is more impressive and far less likely to be an outlier is...
-
- There are more pages in this discussion • 106 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$8.74 |
Change
0.020(0.23%) |
Mkt cap ! $2.762B | |||
| Open | High | Low | Value | Volume |
| $8.70 | $8.80 | $8.48 | $13.70M | 1.580M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $8.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $8.74 | 5916 | 1 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |